Chugai Pharma France clinical trials
Acquired by Hoffmann-La Roche, Oct 1, 2002 · source ↗
The registry lists 2 studies whose lead sponsor is Chugai Pharma France. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Jul 22, 2022.
- 2studies on the registry
- 0open to participants now
Before and after it joined Hoffmann-La Roche
- First submitted before Chugai Pharma France became part of Hoffmann-La Roche
- 0
- First submitted after Chugai Pharma France became part of Hoffmann-La Roche
- 2
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 2 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
- Completed2100%
Where
- France2
Over the years
- 116
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Chugai Pharma France2 studies
Something wrong with this grouping? Tell us on the Hoffmann-La Roche page.
Studies
Recruiting first, then most recently updated. Showing 2 of 2. All Hoffmann-La Roche studies →
- Assessment of Giant Cell Arteritis Medical Practices in FranceCompletedNCT03658889
Sponsor listed in the registry: Chugai Pharma France · First submitted after Chugai Pharma France became part of Hoffmann-La Roche
- Non-interventional Study to Assess the Frequency of Cachexia in Patients With Non-small Cell Lung Cancer.CompletedNCT02968979
Sponsor listed in the registry: Chugai Pharma France · First submitted after Chugai Pharma France became part of Hoffmann-La Roche